Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

January 4, 2023

Study Completion Date

August 25, 2023

Conditions
Cytomegalovirus (CMV) Infection
Interventions
DRUG

Letermovir oral granules

Granules administered orally based on age, weight, and whether participant takes cyclosporin A as a concomitant medication.

DRUG

Letermovir tablet

Tablet administered orally based on age, weight, and whether participant takes cyclosporin A as a concomitant medication.

DRUG

Letermovir intravenous

Letermovir administered intravenously based on age, weight, and whether participant takes cyclosporin A as a concomitant medication.

Trial Locations (40)

2145

The Children s Hospital at Westmead ( Site 0185), Westmead

3052

Royal Childrens Hospital Melbourne ( Site 0181), Parkville

4101

Lady Cilento Children s Hospital ( Site 0182), South Brisbane

10065

Memorial Sloan Kettering Cancer Center ( Site 0254), New York

13353

Charite Universitaetsmedizin Berlin - Campus-Virchow-Klinikum ( Site 0113), Berlin

15224

Children's Hospital of Pittsburgh of UPMC ( Site 0258), Pittsburgh

20246

Universitatsklinikum Hamburg-Eppendorf ( Site 0111), Hamburg

27705

Duke University Health System ( Site 0252), Durham

28009

Hospital Infantil Universitario Nino Jesus ( Site 0151), Madrid

28046

Hospital Universitario La Paz ( Site 0153), Madrid

35040

Ege Univ.Tip Fakultesi Cocuk Has ( Site 0163), Izmir

44340

Nuevo Hospital Civil Dr Juan I Menchaca ( Site 0223), Guadalajara

45229

Cincinnati Children's Hospital Medical Center ( Site 0244), Cincinnati

48149

Universitaetsklinikum Muenster ( Site 0114), Münster

60590

Universitaetsklinikum Frankfurt ( Site 0112), Frankfurt am Main

60637

University Of Chicago School Of Medicine ( Site 0253), Chicago

64460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0222)", Monterrey

75015

Hôpital Universitaire Necker Enfants Malades-, Unite d'Immunologie-Hematologie et Rhumatologie Pedi, Paris

75235

Children's Medical Center ( Site 0257), Dallas

91010

City of Hope Comprehensive Cancer Center ( Site 0251), Duarte

92868

Children's Hospital of Orange County ( Site 0241), Orange

94158

UCSF Benioff Children's Hospital San Francisco ( Site 0245), San Francisco

98105

Seattle Childrens Hospital ( Site 0248), Seattle

760032

Fundacion Valle del Lili ( Site 0212), Santiago de Cali

760042

Centro Medico Imbanaco de Cali S.A ( Site 0211), Santiago de Cali

3109601

Rambam Medical Center ( Site 0121), Haifa

4920235

Schneider Children's Medical Center ( Site 0122), Petah Tikva

5265601

Pediatric Hemato Oncology Safra Children's Hospital, Sheba Medical Center ( Site 0123), Ramat Gan

02115-5737

Boston Children's Hospital ( Site 0243), Boston

050024

Instituto De Cancerologia S.A. ( Site 0213), Medellín

330-8777

Saitama Children's Medical Center ( Site 0202), Saitama

157-8535

National Center for Child Health and Development ( Site 0201), Tokyo

04530

Instituto Nacional de Pediatria ( Site 0224), Mexico City

06720

Hospital Infantil de Mexico ( Site 0221), Mexico City

85-094

Szpital Uniwersytecki nr 1 im. Dr. Antoniego Jurasza w Bydgoszczy ( Site 0141), Bydgoszcz

50-556

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg-Klinika Transplantacji Szpiku, Onkolog, Wroclaw

08025

H. de la Santa Creu I Sant Pau ( Site 0155), Barcelona

08035

Hospital Universitari Vall d Hebron ( Site 0154), Barcelona

01130

Acibadem Adana Hastanesi ( Site 0162), Adana

07070

Akdeniz University Faculty of Medicine ( Site 0161), Antalya

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT03940586 - Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030) | Biotech Hunter | Biotech Hunter